Search Page

1

Cite

Share

PI3K/AKT/mTOR signaling in gastric cancer: Epigenetics and beyond.

Fattahi S, Amjadi-Moheb F, Tabaripour R, Ashrafi GH, Akhavan-Niaki H. Fattahi S, et al. Life Sci. 2020 Dec 1;262:118513. doi: 10.1016/j.lfs.2020.118513. Epub 2020 Oct 1. Life Sci. 2020. PMID: 33011222 Review.

Cite

Share

2

Cite

Share

Cancer immunotherapy: Challenges and limitations.

Taefehshokr S, Parhizkar A, Hayati S, Mousapour M, Mahmoudpour A, Eleid L, Rahmanpour D, Fattahi S, Shabani H, Taefehshokr N. Taefehshokr S, et al. Among authors: fattahi s. Pathol Res Pract. 2022 Jan;229:153723. doi: 10.1016/j.prp.2021.153723. Epub 2021 Nov 28. Pathol Res Pract. 2022. PMID: 34952426 Review.

Cite

Share

3

Cite

Share

LncRNAs as potential diagnostic and prognostic biomarkers in gastric cancer: A novel approach to personalized medicine.

Fattahi S, Kosari-Monfared M, Golpour M, Emami Z, Ghasemiyan M, Nouri M, Akhavan-Niaki H. Fattahi S, et al. J Cell Physiol. 2020 Apr;235(4):3189-3206. doi: 10.1002/jcp.29260. Epub 2019 Oct 8. J Cell Physiol. 2020. PMID: 31595495 Review.

Cite

Share

4

Cite

Share

Reirradiation for Locoregional Recurrent Breast Cancer.

Fattahi S, Ahmed SK, Park SS, Petersen IA, Shumway DA, Stish BJ, Yan ES, Remmes NB, Mutter RW, Corbin KS. Fattahi S, et al. Adv Radiat Oncol. 2020 Dec 17;6(1):100640. doi: 10.1016/j.adro.2020.100640. eCollection 2021 Jan-Feb. Adv Radiat Oncol. 2020. PMID: 33506143 Free PMC article.

Cite

Share

5

Cite

Share

DNA methyltransferases and gastric cancer: insight into targeted therapy.

Fattahi S, Golpour M, Amjadi-Moheb F, Sharifi-Pasandi M, Khodadadi P, Pilehchian-Langroudi M, Ashrafi GH, Akhavan-Niaki H. Fattahi S, et al. Epigenomics. 2018 Nov;10(11):1477-1497. doi: 10.2217/epi-2018-0096. Epub 2018 Oct 16. Epigenomics. 2018. PMID: 30325215 Review.

Cite

Share

6

Cite

Share

The relation between the ghrelin receptor and FOXP3 in bladder cancer.

Karimi M, Heshmati M, Fattahi S, Bagheri N, Alibeigi FM, Taheri F, Anjomshoa M, Jami MS, Ghatreh Samani M. Karimi M, et al. Among authors: fattahi s. Biotech Histochem. 2021 May;96(4):287-295. doi: 10.1080/10520295.2020.1799074. Epub 2020 Aug 3. Biotech Histochem. 2021. PMID: 32744468

Cite

Share

7

Cite

Share

Infection-associated epigenetic alterations in gastric cancer: New insight in cancer therapy.

Fattahi S, Kosari-Monfared M, Ghadami E, Golpour M, Khodadadi P, Ghasemiyan M, Akhavan-Niaki H. Fattahi S, et al. J Cell Physiol. 2018 Dec;233(12):9261-9270. doi: 10.1002/jcp.27030. Epub 2018 Aug 4. J Cell Physiol. 2018. PMID: 30076708 Review.

Cite

Share

8

Cite

Share

The Role of Immune Regulatory Molecules in COVID-19.

Khalifehzadeh-Esfahani Z, Fattahi S, Heidari Haratemeh Z, Jafarinia M. Khalifehzadeh-Esfahani Z, et al. Among authors: fattahi s. Viral Immunol. 2022 Jun;35(5):359-364. doi: 10.1089/vim.2021.0211. Epub 2022 Apr 19. Viral Immunol. 2022. PMID: 35443826 Review.

Cite

Share

9

Cite

Share

Hedgehog signaling pathway: Epigenetic regulation and role in disease and cancer development.

Fattahi S, Pilehchian Langroudi M, Akhavan-Niaki H. Fattahi S, et al. J Cell Physiol. 2018 Aug;233(8):5726-5735. doi: 10.1002/jcp.26506. Epub 2018 Mar 7. J Cell Physiol. 2018. PMID: 29380372 Review.

Cite

Share

10

Cite

Share

PI3K/Akt/mTOR pathway: a potential target for anti-SARS-CoV-2 therapy.

Fattahi S, Khalifehzadeh-Esfahani Z, Mohammad-Rezaei M, Mafi S, Jafarinia M. Fattahi S, et al. Immunol Res. 2022 Jun;70(3):269-275. doi: 10.1007/s12026-022-09268-x. Epub 2022 Feb 2. Immunol Res. 2022. PMID: 35107743 Free PMC article. Review.

Cite

Share